chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vertigo; Brain fog; Extreme Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme Tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo), FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme Tiredness). At the time of the report, VERTIGO (vertigo), FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme Tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.   This case was linked to MOD-2021-404863 (Patient Link).
3/10 - achy, low grade fever. 3/12 - fever 102-103, cough. 3/13 - emesis, HA, photophobia. 3/14 - stiff neck, worse HA. 3/16 - seen in ER, admitted. Given Vancomycin, Rocephin x 48 hrs until CSF, blood csx negative. 3/18 - D/C home - feeling well.  4/1/08 Reviewed hospital medical records of 3/16-3/18/2008. FINAL DX: Viral meningitis Records reveal patient experienced muscle aches approx 1 week prior which progressed to cough, mild SOB, fever, HA, vomiting/diarrhea, stiff neck, photophobia.  Tx w/IV antibiotics, steroids & pain meds.  LP done.  Improved quickly & d/c to home.
upper chest was tight; cough; He gets mucous build up after he eats something; This is a spontaneous report from a contactable consumer (patient himself). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number was not reported, Expiration Date was not reported), via an unspecified route of administration in Mar2021 as unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021 patient stated that the cough just started after he got his COVID-19 vaccine in March of this year. He gets mucous build up after he eats something and that was when he coughs.On an unspecified date, patient mentioned at one time his upper chest was tight and that lasted a few days and then it loosened up. The outcome of the events was unknown.  Follow-up attempts are needed; information about lot/batch number has been requested.
Pt received first dose ever flu vaccine, and MMR/varicella. Approx 10min post vaccination pt presented w/ local redness, swelling on both arms' vaccination site. Assessed pt, known allergy to eggs. Symptoms progressed in swelling of hands & urticaria. Treated successfully w/ BENADRYL, monitored for reaction 1hr and released.
Shingles left chest, Started 08/26/2002, Seen by MD 08/30/2002
Pt. right arm (entire area over bicep red, swollen, tense and warm to touch.
Red, flat, itchy rash on face, arms, chest, back, genitalla and legs erupted on 9/8/2020.  Mom applied Over the counter hydrocortisone cream.
COVID arm: macular-papular rash on anterior of L lore arm and ant tp elbow, tender sc nodules at injection site
This case was reported by a pharmacist via call center representative and described the occurrence of local swelling in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced local swelling. On an unknown date, the outcome of the local swelling was recovered/resolved. It was unknown if the reporter considered the local swelling to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced a knot in the arm after getting the SHINGRIX injection. The event lasted about a week or two. No further clarifications on the event were provided. This case has been linked to case US2018226058 and US2018226062, reported by same reporter.
legs stiff, equilibrium off, felt on edge;felt like this off & on x 2 wks;
Client stated that one week after vaccine administered he experienced redness, warmth and burning of both upper arms.  He also states that he is a dishwasher and had used different soap detergent
Pt was brought to clinic by mother for 2nd Moderna 6 mo through 5 yrs covid vaccine on 8/19/22 at 4:10 p.m.  Vaccine given was the correct med, route, site, dose but vial refrigeration date had expired on 8/7/22.  Overall expiration date to expire was 2/10/23.  Pt received expired medication.
This spontaneous report as received from a pharmacist refers to a 69 year old patient of unknown gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date in April 2016 the reporter stated that the patient who was indicated for ZOSTAVAX accidentally received a dose of VARIVAX (dosing details were not reported). No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Chest pains started around 6:45pm while my son was doing his homework.  He said he laid on the floor in his bedroom for awhile till he has called to walk the dog.  He came downstairs and mentioned he was having chest pains.  He said he didn't tell me because he didn't want to bother me.  I had him stay near me the rest of the evening.  He said laying on his stomach on the floor felt best.  He eventually moved to the couch and sat upright leaning forward since that is what I read that he should do.  After a few hours, he said the pains where subsiding.  In the morning, he said he had no pain and hasn't had the pains since.
slight rash around injection site, with reddish raised skin extending outward from injection site approx 5 cm, more visible/raised when exposed to hot water, persisted for approx 6-7 days before receding  simply reporting for database
Numbness of the arms and went towards her shoulder and to her back/ symptoms have gotten better around the back, chest, and arm but still quite bad; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of the arms and went towards her shoulder and to her back/ symptoms have gotten better around the back, chest, and arm but still quite bad) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Knee operation. Concurrent medical conditions included Allergy to antibiotic (sulfa drug). Concomitant products included GABAPENTIN for Nerve damage, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, unspecified, IBUPROFEN for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness of the arms and went towards her shoulder and to her back/ symptoms have gotten better around the back, chest, and arm but still quite bad). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness of the arms and went towards her shoulder and to her back/ symptoms have gotten better around the back, chest, and arm but still quite bad) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.6 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-129237 (Patient Link).
Information has been received from a medical assistant referring to a 19 years old patient of unknown gender. The patient's pertinent medical histories, concomitant medications and drug reactions or allergies were not reported. On 13-JUL-2017, the patient was administered with M-M-R II (albumin status rHA, lot # M042846, with expiration date 21-OCT-2018) or VARIVAX (lot# N014366, expiration date 09- MAY-2019) (dose, dose#, route of administration and anatomical location were not reported for both of the vaccines) for prophylaxis, which was reconstituted with sterile diluent (lot # N003192 with expiration date at 05-JUL-2019). The administered doses of vaccine were exposed to a temperature excursion between 47 degrees Fahrenheit (F) and 77 degrees Fahrenheit (F) on 09-JUL-2017, which lasted for a 12 hours and 10 minutes. There was no previous temperature excursion reported. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA009993: US-009507513-1707USA002673: US-009507513-1709USA004444.
Pt. developed swelling and erythema on (L) deltoid, erythema measured 4 cm in diameter. Mom reported, child c/o malaise. So brought in to clinic Pt. had been prescribed amoxicillin 2 days ago for an infected, abraded legion on (R) leg.
completed all 4 on 7DEC92 then had a skin react on lt wrist & on back of upper legs; then went back to MD on 16DEC & told it should go away & by then it spread all over turso & under arms;
on 12/7/21 went into full cardiac arrest.  VFib heart condition.  Spent the next 45 days in the hospital.  30 days in ICU, 18 days unconscious, 11 days on life support.  As a result have significant hearing loss in right ear, constant tinnitus, lung function is at 66%, scarring in heart, periodic pvcs, right shoulder damage.  ICD implanted in March 2022 which now restricts some extracurricular activities.  Doctors were not able to determine why I went into cardiac arrest.  I was a healthily individual.  Non smoker, low cholesterol, no blood pressure, active athletic individual.  Athletic activities has been impacted somewhat due to this event.
Approximately 5 minutes after vaccine administered, patient started feeling nauseous and dizzy. She was also pale and clammy.  Offered patient water and allowed to remove face mask. Instructed on breathing slowly in through the nose and out through the mouth. This helped briefly but then patient verbalized that she was feeling more light headed and thought she should lie down on exam table. Remained at patient's side but did not allow her to stand up in order to relocate from chair to exam table. Approximately 7 minutes after vaccine administration, patient briefly lost consciousness for less than 30 seconds and had slight jerking movements during this time. Remained at patient's side and prevented her from falling out of chair, hitting head, or other injury during syncopal event. After patient regained consciousness, she began sipping on water. A cold, wet paper towel was placed to the back of her neck. Continued to observe patient in exam room for another 5 minutes then she was escorted to waiting area by provider. Waiting area was just outside exam room and patient remained in the presence of a patient care technician, as well as her mother. Patient remained in waiting area for a total observation time of 30 minutes. No other adverse events occurred. Patient and mother both reported that patient does not do well after vaccines and has had similar symptoms after other vaccines in the past.
Pt reports-red rash and swelling (hot to the touch) in left arm. Severe redness. MD felt it was cellulitis and prescribed KEFLEX 500mg 1 bid x 10d on 09-03-15.
Shoulder is swollen; Under armpit is swollen; sore shoulder; Some swelling underneath and in my shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder). At the time of the report, PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder) outcome was unknown. Not Provided          Concomitant medication involves: high blood pressure (unspecified)
Beyond use date of vaccine given was 3/16/2023. Patient reported no adverse event or reaction.
Post vaccination fever of 102.2 deg F, erythema at rt leg injection site.
Vasovagal; This is a spontaneous report from a contactable physician reported on behalf of the daughter(patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced vasovagal after injection on an unspecified date with outcome of unknown. Physician asked if Pfizer had any information on syncope in terms with Covid vaccines? He said his daughter had a vasovagal after injection.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Erythemous rash approximately 12cm x 7cm on Right upper deltoid.
Dyspnea on exertion; Acute on chronic systolic (congestive) heart failure; A spontaneous report was received from a other healthcare professional  concerning a 79-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dyspnea exertional and acute on chronic systolic (congestive) heart failure.  The patient's medical history, as provided by the reporter, included pulmonary fibrosis, elevated troponin, paroxysmal trial fibrillation paroxysmal (PAF), major depressive disorder, and cardiac pacemaker insertion.   Concomitant medications was not provided.  On 21 Jan 2021 at 11:30 am, approximately twenty two days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 12 Feb 2021 the patient was hospitalized. Onset of the dyspnea was noted on the same date and acute cardiac failure started on 13 Feb  2021. He was  discharged on 14 Feb 2021.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The events, dyspnea on exertion and acute on chronic systolic (congestive) heart failure considered was recovered/resolved.; Reporter's Comments: Very limited information regarding these events has been provided at this time. Further information is requested.
I had all over body aches for about two days after receiving the vaccine. I tested positive for COVID-19 on 02/14/2023. I contacted my doctor and got a prescription for Paxlovid. I had an upset stomach while taking the medication, but I tolerated it and completed the prescription. It took a long time to get my lungs and respiratory system back to normal.
Chest pain; Joint aches; Body aches; Fever; Chills; Fatigue; Nausea; A spontaneous report was received from a 66 year old, female patient who was participating in the mRNA-1273 Emergency Use Program and experienced chest pain, body and joint aches, fever, chills, fatigue, and nausea.  The patient's medical history was not provided.  No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 on 10-Jan-2021.  On 11-Feb-2021, approximately 2 days prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 intramuscularly for the prophylaxis of COVID-19 infection.   On 11-Feb-2021, the patient developed body and joint aches, chest pains, fever, chills, fatigue, nausea, and just hurt all over and felt terrible. On 12-Feb-2021, the patient's symptoms persisted, and she was in the emergency room (ER) to be treated.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events is not applicable.  The outcome of the events, chest pain, body and joint aches, fever, chills, fatigue, and nausea, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Fever; irritability; morbilliform rash - Information has been received from a pharmacist concerning her 15 month old white daughter who on 21 feb 2001 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot 636657/1160k. On 03/02/01 the patient developed a fever and irritability through to 05 mar 2001. She was treated with acetaminophen tylenol. On 06- Mar 2001 the patient developed a non pruritic generalized rash on her trunk, front and back, which spread to her extremities and under her hairline. The rash had the appearance of a classic measles rash. A physician office note describes the rash as a morbilliform rash on the trunk and proximal upper extremity, not on the lower extremities. There was also some confluent rash behind both ears, and her cheeks were pink. There was no lace like appearance, the rash did not feel rough or sandpapery. There was no axillary, supreclavicular or abdominal adenopathy. On 14 mar 2001 he rash resolved and the patient recovered. No further details were provided. The pharmacist also reported that another child at the same clinic as her daughter, developed the same rash and a fever after receiving measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot 636657/1160k waes 010408383. No further information is available
Hospitalized 12/1/2021-still admitted currently; COVID-19 positive 12/12/2021; fully vaccinated  12/1/2021 admission note: MEDICAL DECISION MAKING:     71-year-old female presents with right upper quadrant tenderness and mild rebound.  Afebrile, review of documentation shows that she recently was diagnosed with biliary sludge in her gallbladder.  Repeat ultrasound here and blood work is obtained, pain control with morphine is ordered.  Her white count returns elevated, her bilirubin, LFTs are bumped, she is covered with ceftriaxone which she has tolerated well in the past and Flagyl.  Her ultrasound shows a thickened gallbladder wall concerning for acute cholecystitis, her CBD is 7 mm which is likely normal for her age.  I spoke with surgery here who is concerned about the possibility of a retained stone given her elevated bilirubin, he recommends transfer.  I spoke with surgery down at another Hospital, they recommend transfer emergency department to emergency department.  The patient is accepted by the emergency department physician for transfer there, is stable for transfer.  Family is updated on the plan and they verbalized understanding all questions are answered. She does have a mild AKI on labs and fluids are given here. She had a recent negative covid.  12/12/2021 note: Date of Admission: Hospital Day: 12   Chief complaint Acute respiratory failure with hypoxia   Assessment and Plan   Acute hypoxic respiratory failure multifactorial COVID-19 pneumonia, COVID-19 PCR positive 12/12 Acute on chronic diastolic heart failure Currently requiring 100% non-rebreather, respiratory consult for high-flow nasal cannula Echo showing severe MR with significant pulmonary hypertension Continue dexamethasone 6 mg daily for 10 days Lasix 40 mg IV 2 times a day Strict I&Os, daily weights, 2 g sodium diet Cardiology consult, follow-up recommendations Continuous pulse ox and tele monitoring Trend D-dimer and CRP 12/18/2021 note: CHIEF COMPLAINT Acute respiratory failure with hypoxia      Assessment/Plan     ASSESSMENT / PLAN  Plan:  -condition with ongoing trend of improvement; oxygenation improved to the point that she has been weaned to standard nasal cannula -no heart failure complaints at present; appears to be relatively euvolemic Acute hypoxic respiratory failure 2/2 CHF and COVID 19  - weaned to nasal cannula - CHF less likely the primary culprit; hypoxia now likely 2/2 COVID   Care Management Note 12/18/2021: SAR recommended Talked with pt and she wants referral to facility Will follow up with facility as they said to check back then. Pts drain still in and IR managing. Pt down to 02 at 4 liters now.  Pts covid isolation to end day 10 is 12/22/21.  cannot to go this SAR unless out of isolation.
The night of the vaccination, while I was sleeping I had very bad rigors. It woke my up and had gelling phenomenon, where my joints were filled and swollen. I called my doctor and referral to a rheumatologist. I could not lift my arm. It was painful. My whole body hurt in my joints and I could not move due to joint swelling in all of my joints, bilaterally with the worse in my shoulders and neck. I also got a large lymph node on my left armpit which was the injection site. My rheumatologist referred to it as gelling phenomenon. Was diagnosis Polymyalgia Rheumatica. I had to get PT and get high dose steroids which I am trying to wean off. When I got to a half a dose, it comes back and I have to take them again. I was out of work for a month. This is affecting my arm strength which is overall arm weakness and hard to work. I still have a lot of joint pain all over and hard getting dressed in the mornings to go to work. I am now on a new medication which takes months to kick in. This is still continuing but the steroids is helping, I just don't need to be on this high of a dose for too long.
On 2-1-18 patient's grandmother noticed a quarter sized red bump on patient's right lateral thigh. On 2-2-18, it had grown in size so he was brought in for an appointment. He was noted to have enlarged nodes in his groin. He was treated with AUGMENTIN for presumed infection (cellulitis of right lower extremity).
Shortness of Breath, Heart Palpitations, Dizziness. It came on within 3-5 minutes of injection and subsided within another 5 minutes.
NAUSEA, CLAMMY PALE SKIN, LOW BLOOD PRESSURE. SLIGHT DIFFICULTY BREATHING EMERGENCY PERSONEL ARRIVED AND TREATED PATIENT FOR AN ALLERGIC REACTION.  EMERGENCY PERSONEL SAID THAT PATIENT WAS HAVING A REACTION, BUT NOT SURE IF IT WAS AN ALLERGIC REACTION.